Patents by Inventor Jared Bruce John Milbank

Jared Bruce John Milbank has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hepatitis C Virus Inhibitors
    Publication number: 20110112100
    Abstract: The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts thereof, to compositions containing such compounds and to the use of such compounds as inhibitors of HCV replication.
    Type: Application
    Filed: August 25, 2010
    Publication date: May 12, 2011
    Inventors: Jared Bruce John Milbank, David Cameron Pryde, Thien Duc Tran
  • N-methyl-substituted benzamidazoles
    Patent number: 7160915
    Abstract: The present invention relates to N-methyl-substituted benzamidazole derivatives of formula (I): as defined in the specification; pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: July 22, 2004
    Date of Patent: January 9, 2007
    Assignee: Warner-Lambert Company, LLC
    Inventors: Stephen Douglas Barrett, Cathlin Marie Flamme, Michael David Kaufman, Jared Bruce John Milbank, Haile Tecle, Joseph Scott Warmus
  • N-(4 substituted phenyl)-anthranilic acid hydroxamate esters
    Patent number: 7078438
    Abstract: The present invention relates to oxygenated esters of 4-substituted-phenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: February 4, 2005
    Date of Patent: July 18, 2006
    Assignee: Warner-Lambert Company
    Inventors: Gordon William Rewcastle, Julie Ann Spicer, Stephen Douglas Barrett, Michael David Kaufman, Jared Bruce John Milbank, Haile Tecle
  • 5-substituted tetralones as inhibitors of ras farnesyl transferase
    Patent number: 6943183
    Abstract: The present invention provides novel 5-substituted tetralones of Formulas I, II, III, and IV and pharmaceutically acceptable salts, esters, amides, and prodrugs thereof, which are useful for treating and preventing uncontrolled or abnormal proliferation of tissues, such as cancer, atherosclerosis, restenosis, and psoriasis.
    Type: Grant
    Filed: April 16, 2001
    Date of Patent: September 13, 2005
    Assignee: Pfizer Inc
    Inventors: William Alexander Denny, Richard H. Hutchings, Douglas S. Johnson, James Stanley Kaltenbronn, Ho Huat Lee, Daniele Marie Leonard, Jared Bruce John Milbank, Joseph Thomas Repine, Gordon William Rewcastle, Andrew David White
  • N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
    Patent number: 6891066
    Abstract: The present invention relates to oxygenated esters of 4-substituted-phenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof.
    Type: Grant
    Filed: January 23, 2003
    Date of Patent: May 10, 2005
    Assignee: Warner-Lambert Company
    Inventors: Gordon William Rewcastle, Julie Ann Spicer, Stephen Douglas Barrett, Michael David Kaufman, Jared Bruce John Milbank, Haile Tecle
  • 5- substituted tetralones as inhibitors of ras farnesyl trransferase
    Publication number: 20040044057
    Abstract: The present invention provides novel 5-substituted tetralones of Formulas (I), (II), (III) and (IV) and pharmaceutically acceptable salts, esters, amides, and prodrugs thereof, which are useful for treating and preventing uncontrolled or abnormal proliferation of tissues, such as cancer, atherosclerosis, restenosis, and psoriasis. Specifically, the present invention relates to compounds that inhibit the farnesyl transferase enzyme.
    Type: Application
    Filed: May 19, 2003
    Publication date: March 4, 2004
    Inventors: William Alexander Denny, Richard H Hutchings, Douglas S Johnson, James Stanely Kaltenbronn, Ho Huat Lee, Daniele Marie Leonard, Jared Bruce John Milbank, Joseph Thomas Repine, Gordon William Rewcastle, Andrew David White
  • N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
    Publication number: 20040006245
    Abstract: The present invention relates to oxygenated esters of 4-substituted-phenylamino benzhydroxamic acid derivatives, pharmaceutical compositions and methods of use thereof.
    Type: Application
    Filed: January 23, 2003
    Publication date: January 8, 2004
    Inventors: Gordon William Rewcastle, Julie Ann Spicer, Stephen Douglas Barrett, Michael David Kaufman, Jared Bruce John Milbank, Haile Tecle